Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

GNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for this essential antibacterial agent, ensuring timely delivery and regulatory compliance.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective for skin, soft‑tissue and pneumonia caused by MRSA.
  • Vancomycin‑resistant Enterococcus (VRE) infections: provides an option when vancomycin is ineffective.
  • Community‑acquired pneumonia (CAP) caused by susceptible Gram‑positive organisms: improves clinical outcomes.
  • Skin and soft‑tissue infections (SSTI) caused by susceptible Gram‑positive bacteria: reduces bacterial load and promotes healing.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex required for translation. This action blocks the early stage of peptide chain assembly, leading to a bacteriostatic effect against susceptible Gram‑positive organisms. It does not affect the 30S subunit and shows minimal activity against most Gram‑negative bacteria, preserving the normal flora. The binding is reversible, allowing normal host protein synthesis to continue.

Side Effects

Linezolid may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools.
  • Headache: transient headache.
  • Metallic taste: altered taste perception.

Serious or Rare Side Effects

  • Thrombocytopenia: reduced platelet count.
  • Peripheral neuropathy: nerve damage with prolonged use.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Optic neuritis: inflammation of the optic nerve.

Precautions & Warnings

Before prescribing Linezolid, consider the following precautions.

  • Renal impairment: dose adjustment may be required.
  • Hepatic dysfunction: monitor liver enzymes.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Long‑term therapy (>14 days): monitor blood counts for myelosuppression.
  • Pregnancy and lactation: use only if benefit outweighs risk.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Linezolid can interact with several medicines; review patient medication lists.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): increased serotonergic toxicity.
  • Rifampicin: reduces linezolid plasma concentrations.
  • Erythromycin: may increase linezolid levels.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible alteration of INR.
  • Anticonvulsants (e.g., carbamazepine): may affect metabolism.
  • NSAIDs: monitor for bleeding risk.

Frequently Asked Questions

Linezolid Krka is used to treat infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired pneumonia, and skin or soft‑tissue infections where these organisms are identified.

Linezolid works by binding to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex needed for protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect against Gram‑positive organisms.

The specific dose of Linezolid Krka is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local treatment guidelines. Only a qualified healthcare professional should set the regimen.

Safety data for linezolid in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only when the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

To order Linezolid Krka, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral bioavailability comparable to intravenous administration, making it convenient for step‑down therapy. Unlike many beta‑lactams, it remains active against MRSA and VRE. However, it is bacteriostatic rather than bactericidal, and its safety profile requires monitoring for hematologic and neurologic effects.

Linezolid Krka should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Linezolid Krka is administered orally, typically as a tablet taken with or without food. The exact dosing schedule and duration are prescribed by a qualified healthcare professional based on the infection being treated.

Serious risks include thrombocytopenia, peripheral neuropathy, optic neuritis, and serotonin syndrome, especially when combined with serotonergic drugs. Patients should be monitored regularly for blood‑cell abnormalities, visual changes, and signs of excessive serotonergic activity.

Linezolid Krka should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, and in individuals taking contraindicated serotonergic agents such as MAO inhibitors. Caution is also advised for patients with severe hepatic or renal impairment until appropriate dose adjustments are made.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT